Arthur S. Przybyl
2017
In 2017, Arthur S. Przybyl earned a total compensation of $3.6M as President, Chief Executive Officer and Director at ANI Pharmaceuticals, a 42% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $506,250 |
|---|---|
| Option Awards | $1,223,600 |
| Salary | $647,270 |
| Stock Awards | $1,175,863 |
| Other | $27,309 |
| Total | $3,580,292 |
Przybyl received $1.2M in option awards, accounting for 34% of the total pay in 2017.
Przybyl also received $506.3K in non-equity incentive plan, $647.3K in salary, $1.2M in stock awards and $27.3K in other compensation.
Rankings
In 2017, Arthur S. Przybyl's compensation ranked 2,936th out of 14,666 executives tracked by ExecPay. In other words, Przybyl earned more than 80.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,936 out of 14,666 | 80th |
Division Manufacturing | 1,009 out of 5,772 | 83rd |
Major group Chemicals And Allied Products | 270 out of 2,075 | 87th |
Industry group Drugs | 206 out of 1,731 | 88th |
Industry Pharmaceutical Preparations | 164 out of 1,333 | 88th |
Source: SEC filing on April 6, 2018.
Przybyl's colleagues
We found three more compensation records of executives who worked with Arthur S. Przybyl at ANI Pharmaceuticals in 2017.